|
BA Venture Partners Announces $400 Million Venture Fund
Focus on Digital Consumer and Therapeutics Drives Investment Strategy
FOSTER CITY, CA-February 14, 2005-BA Venture Partners (BAVP), a venture capital partnership that provides capital and expertise to accelerate market traction for technology and life sciences companies, today announced the closing of BAVP Fund VII, a $400 million fund. BAVP will invest Fund VII over the next four years. "We're planning to invest close to $150 million of the new fund in the digital consumer space, which for us includes every kind of media at the device and content level," said Kate Mitchell, Managing Director of BAVP. "We're also going to expand our historically strong presence in several areas of the therapeutics market, which is attractive given the aging population and the need for more cost-effective, targeted therapies. Most likely we will invest close to $100 million in therapeutic companies alone." Managing Directors of the Fund VII are Kate Mitchell, Lou Bock, Mark Brooks, Rory O'Driscoll, Jim Jones and Sharon Wienbar. The investment team, which also includes four other professionals, will be targeting early-and development-stage opportunities in semiconductors, networking and consumer electronics; internet and wireless services, and software-as-service applications; therapeutics for oncology, inflammation, neurology and dermatology; and medical devices addressing orthopedic, cardiovascular and neurological markets. BAVP foresees a positive investment climate in 2005. The firm expects its total investment level in 2005 to equal or exceed that of 2004, during which they invested $120 million in 32 companies and drove five liquidity events, including two acquisitions and three initial public offerings. Since its inception in 1995, BAVP has successfully funded and actively assisted more than 93 companies. The firm typically leads financing rounds with initial investments of $2-15 million and $5-20 million over the lifecycle of a deal. With more than 100 years of combined experience, BAVP takes an analytical and pragmatic approach toward gaining portfolio company market traction by focusing on strategic operations such as sales, finance, marketing and distribution challenges, as well as developing clinical and regulatory strategies for life sciences. About BA Venture Partners BA Venture Partners is a multi-stage, market-driven venture capital partnership that combines the specialized expertise and management support that today's companies need to quickly generate business momentum. Its partners offer extensive industry experience and resources in software, hardware, biotechnology and medical devices. Recent liquidity events include Citrix's acquisition of Net6, Microsoft's acquisition of PlaceWare, Checkpoint's acquisition of Zone Labs, and Silicon Labs' acquisition of Cygnal in addition to the initial public offerings of Monolithic Power Systems, VNUS, Acusphere and Dynavax. Bank of America is the firm's sole limited partner. For more information, please visit www.baventurepartners.com or call 650-378-6000. # # # For More Information Contact:
|
